Skip to content

chromosomal translocation

Genetics / OncologyHematologic/LymphaticMusculoskeletalReproductiveMultisystem

Summary

A chromosomal translocation is the exchange or transfer of genetic material between nonhomologous chromosomes. It can be balanced (no net loss of material, usually phenotypically normal carrier) or unbalanced (gain or loss of material, causing disease). Translocations are classically tied to malignancies (e.g., t(9;22) CML, t(8;14) Burkitt lymphoma) and to inherited syndromes (e.g., Robertsonian translocation causing familial Down syndrome).

Detail

**Definition and types** - **Reciprocal translocation:** Two nonhomologous chromosomes exchange segments. It is usually balanced, so carriers are typically phenotypically normal. Carriers have a higher risk of infertility, recurrent miscarriage, and offspring with unbalanced gametes (partial trisomy or monosomy) because of abnormal segregation at meiosis. - **Robertsonian translocation:** Two acrocentric chromosomes (13, 14, 15, 21, 22) fuse at the centromere. The short arms are lost, and this is generally harmless because the p arms carry redundant rRNA genes. Carriers have 45 chromosomes. Examples: - Familial Down syndrome: t(14;21) or t(21;21). About 4% of Down syndrome cases are caused by Robertsonian translocation. Recurrence risk is higher when the parent is a carrier. A t(21;21) carrier has a ~100% risk of an affected child. - Patau syndrome (trisomy 13) can also result from Robertsonian translocation. - **Balanced vs. unbalanced:** Balanced means no net gain or loss of genetic material. Unbalanced means net gain or loss, which usually causes congenital anomalies or intellectual disability.

**Pathophysiology in cancer** Somatic translocations cause cancer through two main mechanisms: 1. **Fusion gene formation.** Two genes join to produce a chimeric protein with constitutive activity. 2. **Promoter or enhancer swapping.** A proto-oncogene is placed next to a strong promoter, such as the immunoglobulin gene loci, and is overexpressed.

**High-yield cancer translocations** - **t(9;22) BCR-ABL (Philadelphia chromosome):** CML, and some ALL (poor prognosis). It produces a constitutively active tyrosine kinase. Treat with imatinib, dasatinib, or nilotinib. - **t(8;14) c-MYC–IgH:** Burkitt lymphoma. It is associated with EBV and shows a "starry sky" histology. - **t(14;18) IgH–BCL2:** Follicular lymphoma. BCL2 overexpression blocks apoptosis. - **t(11;14) cyclin D1 (BCL1)–IgH:** Mantle cell lymphoma (CD5+). - **t(15;17) PML-RARα:** AML M3 (acute promyelocytic leukemia). It is associated with DIC and Auer rods. Treat with all-trans retinoic acid (ATRA) and arsenic trioxide. - **t(12;21) ETV6-RUNX1:** Pediatric B-ALL, with a good prognosis. - **t(8;21) RUNX1-RUNX1T1:** AML with a good prognosis. - **inv(16) / t(16;16) CBFB-MYH11:** AML M4Eo. - **t(11;22) EWS-FLI1:** Ewing sarcoma (small round blue cells, "onion skin" periosteal reaction). - **t(X;18) SYT-SSX:** Synovial sarcoma. - **t(12;16) FUS-DDIT3:** Myxoid liposarcoma. - **t(2;13) PAX3-FOXO1:** Alveolar rhabdomyosarcoma. - **t(X;11) / t(11;X):** Seen in some translocation renal cell carcinomas (TFE3). - **t(2;5) NPM-ALK:** Anaplastic large cell lymphoma. - **EML4-ALK (inversion on 2p):** A subset of lung adenocarcinomas, treated with ALK inhibitors such as crizotinib. - **t(4;14) / t(11;14):** Multiple myeloma. - **t(X;1), t(X;17):** Papillary renal cell carcinoma (TFE3). - **t(1;13):** Alveolar rhabdomyosarcoma variant.

**Other inherited or syndromic translocations** - **Cri-du-chat** (5p deletion) can be caused by parental translocation. - **Chronic translocation-related infertility:** Balanced carriers can have recurrent pregnancy loss.

**Diagnosis** - **Karyotyping** (G-banding) detects large translocations. - **FISH** detects specific translocations, such as BCR-ABL, in interphase cells. - **PCR / RT-PCR** detects fusion transcripts and is used to monitor minimal residual disease (e.g., BCR-ABL in CML). - **Chromosomal microarray** does not detect balanced translocations because it detects copy number changes only.

**Clinical pearls for boards** - A history of recurrent miscarriages should prompt parental karyotyping to look for a balanced translocation. - Translocation Down syndrome is not associated with advanced maternal age, unlike the nondisjunction form (~95% of cases). - The Philadelphia chromosome is the classic example of a targetable fusion product (tyrosine kinase inhibitors). - Nomenclature: t(A;B)(p;q) lists the chromosomes involved, with the lower number first.

Sources

  • First Aid for the USMLE Step 1 (Genetics; Hematology/Oncology)
  • Robbins & Cotran Pathologic Basis of Disease (Genetic Disorders; Neoplasia)
  • Thompson & Thompson Genetics in Medicine
  • Pathoma (Fundamentals of Pathology) – Neoplasia and Hematopathology
  • UpToDate: Chromosomal translocations and cancer

Reviewed by Medusa editorial — medical student review. Information here is for study reference only and is not medical advice. Spotted an error? Let us know.